SCHEMBL14835293

SCHEMBL14835293

CCOC(=O)c1cccc(CCCBr)n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.64
MAPT P10636 3/20 0.52
GAA P10253 2/20 0.44
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
ADORA3 P0DMS8 2/20 0.41
ALDH1A1 P00352 4/20 0.40
POLB P06746 2/20 0.40
MAPK1 P28482 1/20 0.40
TSHR P16473 1/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRB2 P47870 1/20 0.39
KCNH2 Q12809 1/20 0.39
CYP4F2 P78329 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2108801 0.88 CYP1A2 (0.72) CYP1A2MAPTGAACA12CA1
SCHEMBL22335924 0.86 CYP1A2 (0.64) CYP1A2MAPTGAACA12CA1
SCHEMBL9498762 0.86 CYP1A2 (0.64) CYP1A2MAPTGAACA12CA1
SCHEMBL9993619 0.85 CYP1A2 (0.72) CYP1A2MAPTGAACA12CA1
SCHEMBL22070741 0.84 CYP1A2 (0.62) CYP1A2MAPTGAACA12CA1
SCHEMBL31185994 0.84 CYP1A2 (0.70) CYP1A2MAPTGAACA12CA1
SCHEMBL28034344 0.82 CYP1A2 (0.68) CYP1A2MAPTGAACA12CA1
SCHEMBL7336055 0.82 CYP1A2 (0.77) CYP1A2MAPTGAACA12CA1
SCHEMBL31186195 0.81 CYP1A2 (0.66) CYP1A2MAPTGAACA12CA1
SCHEMBL536661 0.80 CYP1A2 (0.74) CYP1A2MAPTGAACA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2576510-A1 PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER Amgen Inc. (US) 2013-04-10 EP disclosed
WO-2011153509-A1 PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER AMGEN INC. (US) 2011-12-08 WO disclosed